U.S. flag

An official website of the United States government

NM_000104.4(CYP1B1):c.343G>C (p.Ala115Pro) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 6, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003230872.1

Allele description [Variation Report for NM_000104.4(CYP1B1):c.343G>C (p.Ala115Pro)]

NM_000104.4(CYP1B1):c.343G>C (p.Ala115Pro)

Gene:
CYP1B1:cytochrome P450 family 1 subfamily B member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p22.2
Genomic location:
Preferred name:
NM_000104.4(CYP1B1):c.343G>C (p.Ala115Pro)
HGVS:
  • NC_000002.12:g.38075046C>G
  • NG_008386.2:g.6056G>C
  • NM_000104.3:c.343G>C
  • NM_000104.4:c.343G>CMANE SELECT
  • NP_000095.2:p.Ala115Pro
  • NC_000002.11:g.38302189C>G
Protein change:
A115P
Molecular consequence:
  • NM_000104.4:c.343G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003928784Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Apr 6, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Angiopoietin receptor TEK interacts with CYP1B1 in primary congenital glaucoma.

Kabra M, Zhang W, Rathi S, Mandal AK, Senthil S, Pyatla G, Ramappa M, Banerjee S, Shekhar K, Marmamula S, Mettla AL, Kaur I, Khanna RC, Khanna H, Chakrabarti S.

Hum Genet. 2017 Aug;136(8):941-949. doi: 10.1007/s00439-017-1823-6. Epub 2017 Jun 15.

PubMed [citation]
PMID:
28620713
PMCID:
PMC5953556

Mutation spectrum of the CYP1B1 gene in Indian primary congenital glaucoma patients.

Reddy AB, Kaur K, Mandal AK, Panicker SG, Thomas R, Hasnain SE, Balasubramanian D, Chakrabarti S.

Mol Vis. 2004 Sep 30;10:696-702.

PubMed [citation]
PMID:
15475877
See all PubMed Citations (3)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003928784.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: CYP1B1 c.343G>C (p.Ala115Pro) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1e-05 in 200844 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.343G>C has been reported in the literature in homozygous individuals affected with Primary Congenital Glaucoma (example: Reddy_2004 and Sheikh_2014), however in one these families the variant was also observed in five homozygous clinically normal individuals (Sheikh_2014). Since the penetrance of Primary Congenital Glaucoma (0.44) due to this variant appears to be lower than expected (0.8), no conclusions can be drawn from these data. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 10, 2023